Explore

Trendline Trendline
Daiichi Sankyo Announces Ambitious Five-Year Plan for Oncology Leadership

Daiichi Sankyo Announces Ambitious Five-Year Plan for Oncology Leadership

Daiichi Sankyo Announces Ambitious Five-Year Plan for Oncology Leadership
Trendline Trendline
Immunai Expands Collaboration with AstraZeneca in $37.5 Million Deal

Immunai Expands Collaboration with AstraZeneca in $37.5 Million Deal

Immunai Expands Collaboration with AstraZeneca in $37.5 Million Deal
Trendline Trendline
Puma Biotechnology Raises 2026 Revenue Guidance Amid NERLYNX Demand

Puma Biotechnology Raises 2026 Revenue Guidance Amid NERLYNX Demand

Puma Biotechnology Raises 2026 Revenue Guidance Amid NERLYNX Demand
Trendline Trendline
Nektar Therapeutics Strengthens Financial Position Amidst Development of Lead Biologic Candidate

Nektar Therapeutics Strengthens Financial Position Amidst Development of Lead Biologic Candidate

Nektar Therapeutics Strengthens Financial Position Amidst Development of Lead Biologic Candidate
Trendline Trendline
Arrowhead Pharmaceuticals Reports Strong Q2 2026 Financial Results

Arrowhead Pharmaceuticals Reports Strong Q2 2026 Financial Results

Arrowhead Pharmaceuticals Reports Strong Q2 2026 Financial Results
Trendline Trendline
Zura Bio Reports Strong Financial Position and Progress in Clinical Trials

Zura Bio Reports Strong Financial Position and Progress in Clinical Trials

Zura Bio Reports Strong Financial Position and Progress in Clinical Trials
Trendline Trendline
Windward Bio Secures $165 Million for TSLP Drug Development Amidst Competitive Market

Windward Bio Secures $165 Million for TSLP Drug Development Amidst Competitive Market

Windward Bio Secures $165 Million for TSLP Drug Development Amidst Competitive Market
Trendline Trendline
Immunai and AstraZeneca Expand Collaboration to Enhance Oncology Drug Development

Immunai and AstraZeneca Expand Collaboration to Enhance Oncology Drug Development

Immunai and AstraZeneca Expand Collaboration to Enhance Oncology Drug Development
Trendline Trendline
Soligenix Reports First Quarter 2026 Financial Results Amid Clinical Trial Challenges

Soligenix Reports First Quarter 2026 Financial Results Amid Clinical Trial Challenges

Soligenix Reports First Quarter 2026 Financial Results Amid Clinical Trial Challenges
Trendline Trendline
BioLife Solutions Reports 25% Revenue Growth in Q1 2026, Driven by Cell and Gene Therapy Market

BioLife Solutions Reports 25% Revenue Growth in Q1 2026, Driven by Cell and Gene Therapy Market

BioLife Solutions Reports 25% Revenue Growth in Q1 2026, Driven by Cell and Gene Therapy Market
Trendline Trendline
Maravai LifeSciences Reports Significant Revenue Growth in Q1 2026 Amid Strong Demand

Maravai LifeSciences Reports Significant Revenue Growth in Q1 2026 Amid Strong Demand

Maravai LifeSciences Reports Significant Revenue Growth in Q1 2026 Amid Strong Demand
Trendline Trendline
Soligenix Reports Financial Results and Updates on Rare Disease Treatments

Soligenix Reports Financial Results and Updates on Rare Disease Treatments

Soligenix Reports Financial Results and Updates on Rare Disease Treatments